Aurinia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$16.35

+0.22 (+1.36%)

As of Aug 8, 1:36 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 4 31%

Sell 0 0%

Price Target

Analyst Price Target +148.6% upside

Low Target $34.07

Average Target $40.64

High Target $61.77

Current Price $16.35

Current
$16.35

Target
$40.64

$34.07 $40.64 avg $61.77

Scenario Analysis

Bear Case

$34.07

108.4%

Low target

Base Case

$40.64

+148.6%

Avg target

Bull Case

$61.77

+277.8%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$19.25

-15.1% from high

52-Week Low

$10.34

+58.1% from low

Target vs 52W High

$40.64

+111.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%